Íkaro Breder

Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial

Andrei C. Spósito, Íkaro Breder, Joaquim Barreto et al. · Cardiovascular Diabetology · 2022 · 19 citations · Full text

Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial

Íkaro Breder, Jessica Cunha Breder, Isabella Bonilha et al. · Therapeutic Advances in Chronic Disease · 2020 · 13 citations · Full text

Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus

Vaneza Lira Waldow Wolf, Íkaro Breder, Luiz Sérgio Fernandes de Carvalho et al. · Nutrition and Diabetes · 2021 · 12 citations · Full text

Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: A randomized controlled trial

Vicente Fernandes, Fernando Rodrigo Pedreira Chaves, Alexandre Soares et al. · Diabetes & Metabolism · 2021 · 12 citations

Metabolic Syndrome, Diabetic Retinopathy, Ocular Disease +10

Three new Brazilian cases of 17α-hydroxylase deficiency: clinical, molecular, hormonal, and treatment features

Íkaro Breder, Heraldo Mendes Garmes, Taís Nitsch Mazzola et al. · Journal of Pediatric Endocrinology and Metabolism · 2018 · 11 citations